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Annually, more than a million persons experience traumatic brain injury (TBI) in the US and
a substantial proportion of this population develop debilitating neurological disorders, such
as, paralysis, cognitive deﬁcits, and epilepsy. Despite the long-standing knowledge of the
risks associated with TBI, no effective biomarkers or interventions exist. Recent evidence
suggests a role for inﬂammatory modulators inTBI-induced neurological impairments. Cur-
rent technological advances allow for the simultaneous analysis of the precise spatial and
temporal expression patterns of numerous proteins in single samples which ultimately can
lead to the development of novel treatments. Thus, the present study examined 23 differ-
ent cytokines, including chemokines, in the ipsi and contralateral cerebral cortex of rats
at 24 h after a ﬂuid percussion injury (FPI). Furthermore, the estimation of cytokines were
performed in a newly developed multiplex assay instrument, MAGPIX (Luminex Corp), and
compared with an established instrument, Bio-Plex (Bio-Rad), in order to validate the newly
developed instrument. The results show numerous inﬂammatory changes in the ipsi and
contralateral side after FPI that were consistently reported by both technologies.
Keywords: cytokine,TBI, fluid percussion injury, multiplex assay
INTRODUCTION
It has been estimated that between one and two million per-
sons in the United States are subjected to traumatic brain injury
(TBI) each year and that approximately 230,000 are hospitalized
(Dempsey et al., 2009). There are more than 50,000 deaths from
TBI annually. These ﬁgures do not include the often devastating
injuries to the members of the armed forces, the number and
severity of which represent classiﬁed information. Furthermore,
data from the Center for Disease Control and Prevention have
provided the estimate that more than 80,000 Americans develop
long-term disability related to TBI each year and that 3.2 mil-
lion individuals in the USA are living with such disabilities, not
including the military veterans. Therefore, it is of great impor-
tance to better understand the underlying mechanisms of this
type of neuropathology. It is known that neuroinﬂammatory cas-
cades are initiated following TBI (Pleines et al., 2001) and there
are scant reports that inhibiting neuroinﬂammation following
TBI may improve functional outcomes (Chen et al., 2008; Hart-
ing et al., 2008). Because of the complex milieu of inﬂammatory
proteins, systematic estimation of cytokine expressions is of vital
importance. This is magniﬁed by the fact that some inﬂammatory
proteins can be both, beneﬁcial and detrimental, depending on
when and where they are released, as well as their relative con-
centration within the overall milieu of the inﬂammatory proteins.
Thus, describing the precise temporal and spatial expression pat-
terns of inﬂammatory proteins after TBI can lead to improved
diagnosis and treatment.
Cytokines, including chemokines, play a critical role in medi-
ating inﬂammation. Although altered levels of various cytokines
were reported 24 h after TBI-induced in the lateral ﬂuid percussion
injury (FPI) model (Knoblach and Faden, 2000), a comprehensive
analysis of proinﬂammatory and anti-inﬂammatory proteins after
FPI is lacking in the ﬁeld. The optimum method to detect the
level of different cytokines in the brain would be using a multiplex
assay instrument. Simultaneous estimation of multiple analytes in
biological samples using multiplex assay technology has recently
become a powerful technique in research and clinical laboratories
(Kingsmore, 2006; Ellington et al., 2010). However, the availability
of multiplex assay data from brain analysis is relatively limited.
Estimation of a single analyte, using traditional immunosorbent
assays has been used for more than ﬁve decades. However, detec-
tion of several analytes using monoplex immunoassay such as
enzyme-linked immunosorbent assay (ELISA) has several short-
comings. These include: the requirement of large volumes of
sample, lengthy time period for detection, as well as being labor
intensive and relatively expensive. Multiplex assay uses the same
principle of ELISA but overcomes single analyte limitations.
The basicmultiplex assaymethod uses protein, peptide, or anti-
bodies to tag individual analytes in the biological tissue samples
(Ellington et al., 2010) and is subsequently detected by using dif-
ferent labeled reporter ligands. Alternate methods of label-free
detection technologies are also available, such as, detection tech-
nologies based on piezoelectric acoustic sensors (Luo et al., 2006)
and spinning-disk microinterferometry (Varma et al., 2004).
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Based on the dimensions of the reactive space, multiplex
immunoassay systems are primarily classiﬁed as planar assays
and suspension microsphere assays. The mini-immunoassay in
the two dimensional planar assays, gives better lower limit of
quantiﬁcation because of lower signal to noise ratio and shorter
diffusion time compare to traditional immunoassay (Ekins, 1989).
The three dimensional suspension multiplexes use microspheres
which act as a solid support towhich captured ligands are attached.
The ﬂuid-phase kinetics of suspension arrays are faster than the
solid-phase kinetics of planar arrays. In addition, other advan-
tages of suspension arrays are custom multiplex assays and greater
precision due to measurements of hundreds of beads for each
analyte (Kingsmore, 2006). The established solution-based for-
mats, however, require specialized ﬂow cytometry equipment for
sample analysis, lasers to excite the reporting ligand and associated
optics to measure the biochemical reactions that occur on the sur-
face of the microspheres. Additionally, it also uses a digital signal
processor that manages the ﬂuorescent intensity depending on the
concentration of the analytes present in the tissue.
Recently, a newdetection technologywas developedwhere light
emitting diodes (LEDs) are used instead of laser, for identifying
beads and for exciting the reporting ligand. The resultant ﬂuores-
cent signal is captured by charged coupled device (CCD) imager.
The concentration of the analytes in the biological sample is then
reported by the software, depending on the ﬂuorescent intensity
in the sample. The introduction of this new detection technology
demands validation of this technique with respect to traditional
laser excitation and digital signal processing.AlthoughCCD imag-
ing technology for themultiplex assaywas recently used tomeasure
the chemiluminescence from ELISA to detect six analytes in the
human sera (Urbanowska et al., 2006), no studies have directly
compared multiplex assay results obtained from laser and digital
signal processors with the newer, LED and CCD image analysis.
This study aimed at determining the cortical level of 23
cytokines, on the ipsilateral and contralateral cortex, 24 h after
FPI. Additionally, it also aimed at comparing cytokine levels from
identical samples across two distinct multiplex assays. The results
demonstrate that FPI results in modulation of cytokines in the
cortex and that the data generated by the two different multiplex
assay instruments are very similar.
MATERIALS AND METHODS
All experimental protocols were approved by the InstitutionalAni-
mal Care Committee (IACUC) of Texas A&M University, Health
Science Center and Scott & White hospital. Animals were initially
housed 2 per cage and singly after surgery with a 12-h light–dark
cycle (light on 6:00 and light off 18:00). All animals had contin-
uous access to food and water. Twenty male Sprague Dawley rats,
9–10weeks of age and weighing between 275 to 310 g were used in
this study. Rats were randomly assigned to either the experimental
group or the sham group, so that each group had 10 rats.
Rats were initially anesthetized with 4% isoﬂurane and oxygen
for anesthesia induction and later the concentration of isoﬂu-
rane was reduced to 2% for maintenance. Once under anesthesia,
the heads of the animals were shaved. Strict sterile technique was
maintained during surgical procedures. Animals were placed in a
stereotaxic instrument (Stoelting, Illinois) and a 2-mm burr hole
was drilled on the skull over the left parietal cortex, at 2mm pos-
terior and 3mm lateral from the bregma, as previously described
(D’Ambrosio et al., 2004). A female Luer-Lok cannula was then
secured to the skull with dental cement (PlasticOne). The animals
were connected to the ﬂuid percussion instrument (custom design
and fabrication from the radiology department from VCU, Model
01-B) via the Luer-Lok. A single 4–4.25 atm pressure pulse was
delivered, with a duration of 18–20ms, as measured by a digi-
tal Oscilloscope (Tenma model # 728395), connected to a signal
transducer hooked in-line between the ﬂuid percussion cylinder
and the syringe. Sham animals were anesthetized and manipu-
lated in an identical manner, but no pressure pulse from the ﬂuid
percussion instrument was delivered.
At 24 h after FPI or sham surgery, animals were deeply anes-
thetized with Euthasol (390mg pentobarbital sodium and 50mg
phenytoin sodium i.p) as describedpreviously (Foresti et al.,2009).
Animals were decapitated, the brains rapidly removed and the ipsi
and contralateral cortices, corresponding to cingulated, retrosple-
nial, primary and secondary visual cortex, and motor cortex, were
dissected out and immediately frozen in liquid nitrogen.
MULTIPLEX ASSAYS
In order to quantify the analytes within the tissue, two distinct
multiplex instruments were used,Bio-Plex200 andMAGPIX. Both
instruments use “xMAP” technology based microspheres that
enables detection of protein or nucleic acid concentrations of spe-
ciﬁc analytes.Whereas typical ﬂow cytometry based assays identify
a combination of different sizes and color intensity of micros-
pheres, xMAP technology uses a ﬁxed size microsphere (5.6μ
polystyrene or 6.45μ magnetic microspheres). These micros-
pheres are ﬂuorescent–dyed and dually act as analyte identiﬁer,
as well as to provide a solid surface to build the assay. It should be
noted that the analysis comparing both machines was performed
using the same analytes and the same tissue homogenates.
While both the Bio-Plex and MAGPIX system use the same
beads for analysis, the method of detection is different. Bio-Plex
uses ﬂow cytometry principle to quantify the analytes. This is
accomplished by ﬂuid ﬂow to align beads single ﬁle through a
cuvette. Dual lasers excite each bead and the ﬂuorescence from the
beads is measured with avalanche photodiodes (bead identiﬁca-
tion) and a photomultiplier tube (reporter signal). Alternatively,
MAGPIX ﬂows the magnetic beads with less ﬂuid volume into
a chamber, where they are held in a monolayer by a magnet,
where the beads are imaged with a CCD camera. The software
processes the image to deliver the assay results. Table 1 highlights
the difference between Bio-Plex, MAGPIX, and traditional ELISA.
Frozen tissue was homogenized following the manufacturer’s
instructions (Milliplex MAP kit, Millipore) and 25 μl of undi-
luted homogenate was added to 25ml of assay buffer. Then, 25ml
of magnetic beads (bead size = 6.45μ) coated with speciﬁc anti-
bodies (RCYTOMAG-80K-PMX, Milliplex MAP Kit, Millipore)
was added to this solution and the reaction was incubated at 4˚C
for 24 h. Next, the beads were washed and incubated with 24ml
of biotinylated detection antibody at room temperature (RT) for
2 h. To complete the reaction 25ml of Streptavidin–Phycoerythrin
conjugate compound was added and allowed to incubate for
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Table 1 | Comparisons of traditional ELISA with two multiplexing methods.
Factors ELISA Bio-Plex MAGPIX
Expense (multiple analytes) Most expensive Less expensive Least expensive
Time required (multiple analytes) Most time consuming Less time consuming Least time consuming
Labor intensive (multiple analytes) Most Least Least
Analyte(s) estimated 1 Up to 100 Up to 50
Sample required Most Least Least
Reagent needed Most Least Least
Primary hybridization technique Multiple wells coated/uncoated
with antibody
Antibody attached to magnetic beads
and non-magnetic beads
Antibody attached to magnetic
beads only
Reporter technique Spectrophotometer Laser and photomultiplier tube LED CCD imager
Time to read Minutes after color development 45min 60min
30min at RT. The beads were then washed and incubated with
150ml of sheath ﬂuid for 5min at RT.
The samples were analyzed ﬁrst on the Bio-Plex and then on
MAGPIX instruments. The detection systems in both machines
are different. Bio-Plex, uses two lasers, the ﬁrst to excite the
internal dyes marking the microsphere set and the second laser
excites the Streptavidin–Phycoerythrin conjugate on the reporter
molecule. A high-speed digital processor identiﬁes each individ-
ual microsphere and quantiﬁes the result based on ﬂuorescent
reporter signals. MAGPIX on the other hand, uses red LED instead
of a laser to excite the dyes in the beads for identiﬁcation of
speciﬁc analytes and green LED to excite the reporter ligand.
The acquisition of the ﬂuorescent signal is achieved by a CCD
imager. The concentration of the analytes is then determined
by Bio-Plex Manager version 5.0 and MAGPIX xPONENT soft-
ware, respectively. The assays were run in triplicate to conﬁrm the
results. Analytes were normalized to total protein concentration
which was estimated with a Bradford assay, a colorimetric protein
assay.
Twenty three analytes were studied: interleukin 1 alpha (IL-
1α), interleukin 1 beta (IL-1β), interleukin-2 (IL-2), interleukin-
4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-
10 (IL-10), interleukin-12p70 (IL-12p70), interleukin-13 (IL-13),
interleukin-17 (IL-17), interleukin-18 (IL-18), interferon gamma
(IFN γ) induced protein 10 (IP-10), chemokine C-C motif lig-
and 2 (CCL2, previously known as monocyte chemoattractant
protein 1, MCP-1), chemokine C-C motif ligand 3 (CCL3, previ-
ously known as macrophage inﬂammatory protein 1 alpha, MIP
1α), chemokine C-C motif ligand 5 (CCL5, also known as Regu-
lated upon Activation Normal T-cell Expressed, RANTES), tumor
necrosis factor alpha (TNFα), vascular endothelial growth fac-
tor (VEGF), eotaxin, growth related oncogene KC (GRO KC),
IFN γ, leptin, granulocyte colony-stimulating factor (GCSF), and
granulocyte-macrophage colony-stimulating factor (GMCSF).
DATA ANALYSIS
To determine the effect of FPI, ipsilateral, and contralateral cor-
tical data from each machine were compared separately, using
Student’s t -test. SPSS software (9.0) was used to perform the
regression analysis and Microsoft excel (version 2007) was used
for performing t -test. Datasets from MAGPIX and from Bio-Plex
were compared using linear regression. One of the animals in the
FPI group had a substantial hematoma and was excluded from the
study, resulting in an n of 9 for FPI group, compared with n of 10
for the sham group.
POST HOC ELISA ANALYSIS OF IL-10 AND CCL3
In order to examine the possible differences in type 1 vs. type 2
error, the multiplex data generated from the two machines was
further examined using a traditional ELISA for IL-10 (Ray Biotech
Inc., ELR-IL-10) and CCL3 (Signosis, EA-3008). This analysis was
performed using homogenates from the same rats as those used
for the multiplex assays. A t -test was performed to analyze the data
using Microsoft Excel (version 2007).
RESULTS
INFLAMMATORY EFFECTS OF FPI IN THE IPSILATERAL CORTEX
Fluid percussion injury resulted in signiﬁcant alterations of
cytokines in the ipsilateral cortex after 24 h (Figure 1). In most
cases, the differences reported by both machines exhibited similar
patterns and magnitudes of changes (Figure 1). More speciﬁ-
cally, FPI resulted in a fourfold increase in CCL2 (p = 0.01 for
Bio-Plex andMAGPIX;Figures 1A,C). Similarly,TNFαwas signif-
icantly increased after FPI (p = 0.031 for Bio-Plex and p = 0.025
for MAGPIX; Figures 1B,D). A decrease in IL-1β was observed
by both instruments (p = 0.006 for Bio-Plex and p = 0.012 for
MAGPIX; Figures 1A,C). IFNγ decreased in the data obtained
from the Bio-Plex system (p = 0.03) and showed a trend toward
decrease in the MAGPIX system (p = 0.089, NS; Figures 1B,D).
On the other hand, IL-10 signiﬁcantly decreased after FPI using
the Bio-Plex system (p = 0.011; Figures 1A,C), but no signiﬁcant
differencewas found using theMAGPIX.A trend toward increased
CCL3 and IL-6 was observed using both instruments (p = 0.091
for Bio-Plex and p = 0.078 for MAGPIX) and (p = 0.072 for
Bio-Plex and p = 0.067 for MAGPIX; Figures 1A,C), respec-
tively. It should be further noted that for GCSF and VEGF,
the multiplex instruments failed to report a value because the
levels were below the detection threshold of both instruments.
Therefore statistical analysis could not be performed in these
cases.
EFFECT OF FPI IN THE CONTRALATERAL CORTEX
Similar to the ipsilateral cortex, a signiﬁcant increase in CCL2
(p = 0.023 for Bio-Plex and p = 0.017 for MAGPIX) was observed
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FIGURE 1 | Effect of LFP on the ipsilateral cortex. (A,B) illustrate
the results generated by the Bio-Plex instrument. (C,D) illustrate the
results generated by the MAGPIX instrument. Black ﬁlled bars
denote the value from sham group. The white bars denote the value
from FPI group. Results were compared with Student’s t -test.
Values: mean±SEM; *p<0.05 compared with sham group; #
denotes trend toward signiﬁcance. For details and p value, please
see text.
FIGURE 2 | Effect of LFP on the contralateral cortex. (A,B)
illustrate the data generated by the Bio-Plex instrument. (C,D)
illustrate the results generated by MAGPIX instrument. Black ﬁlled
bars denote the value from sham group. The white bars denote the
value from LFP group. Results compared with Student’s t -test.
Values: mean±SEM; *p<0.05 compared with sham group; #
denotes trend toward the level of signiﬁcance. For details and p
value, please see text.
in the contralateral cortex (Figures 2A,C). A signiﬁcant increase
in IL-18 (p = 0.023) both for Bio-Plex and MAGPIX also was
observed after FPI (Figures 2A,C). CCL3 was signiﬁcantly
increased after FPI when analyzed with the Bio-Plex (p = 0.041),
whereas the data obtained from MAGPIX were not signiﬁ-
cant (p = 0.12, NS; Figures 2A,C). A trend toward increased
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GRO KC (p = 0.073 for Bio-Plex and p = 0.072 for MAGPIX)
and IL-1β (p = 0.084 for Bio-Plex and p = 0.069 for MAG-
PIX) was detected by both instruments Figures 2A,C). On the
contrary, a trend toward decreased IL-17 (p = 0.087 for Bio-
Plex and p = 0.081 for MAGPIX), IL-10 (p = 0.087 for Bio-
Plex and p = 0.081 for MAGPIX), IL-5 (p = 0.089 for Bio-Plex
and p = 0.073 for MAGPIX) and IP-10 (p = 0.089 for Bio-Plex
and p = 0.061 for MAGPIX) was observed for both instruments
(Figures 2A–D). A signiﬁcant decrease in IFNγ (p = 0.025 for
Bio-Plex and p = 0.009 for MAGPIX) and GMCSF (p = 0.027
for Bio-Plex and p = 0.04 for MAGPIX) was observed after
FPI (Figures 2B,D). A trend toward decreased IL-5 (p = 0.089
for Bio-Plex and p = 0.073 for MAGPIX) and IP-10 (p = 0.089
for Bio-Plex and p = 0.061 for MAGPIX) was also observed
(Figures 2B,D).
Because of the minor differences in the detection of IL-10 (sig-
niﬁcantly decreased in the ipsilateral cortex in Bio-Plex data only)
and CCL3 (signiﬁcantly increased in Bio-Plex data only in the
contralateral cortex only) between the two machines, a traditional
ELISA was performed for these two analytes to clarify the discrep-
ancy. Result from the ELISA showed that in the ipsilateral cortex,
IL-10 was signiﬁcantly decreased in the FPI animals (80.9± 7.7 in
the sham animals vs. 57.5± 4.8 in the FPI animals, p = 0.02), con-
sistent with the result from Bio-Plex. Similarly, analysis of CCL3
using ELISA showed that FPI resulted in a signiﬁcant increase in
CCL3 (3.0± 0.3 in the sham vs. 3.9± 0.3, p = 0.033) in the con-
tralateral cortex. This result was also consistent with the Bio-Plex
analysis. In addition, ELISA showed no signiﬁcant differences in
CCL3 (3.0± 0.3 in the sham vs. 15.6± 9.2 in the FPI, p = 0.19)
in the ipsilateral cortex, consistent with both machines. Similarly,
the ELISA data for IL-10 in the contralateral cortex were also con-
sistent with both machines, where no signiﬁcant differences were
detected (51.8± 5.4 in sham vs. 51.1± 3.9).
SIMILAR RESULTS USING TWO DISTINCT TYPES OF DETECTION
MAGPIX and Bio-Plex instruments generated similar data when
compared using linear regression analysis (Tables 2 and 3). The
means of a particular analyte generated by the Bio-Plex matches
very closely with that generated by MAGPIX, as indicated by sim-
ilar means and signiﬁcant R2 values. Only, IL-5 and IFNγ in
contralateral FPI group showed relatively low regression values
(R2∼ 0.45), despite the fact that the MAGPIX and Bio-Plex have
almost identical means in these groups.
DISCUSSION
The present study demonstrates that data obtained using newer
LED and CCD technology (MAGPIX) is consistent with data
Table 2 | Comparison of the level of analytes in the cortex detected by Bio-Plex vs. MAGPIX 24h after FPI.
Analytes Sham R2 FPI R2
Bio-Plex MAGPIX Bio-Plex MAGPIX
IL-1α (ipsi) 3.4±0.4 4.2±0.4 (0.933)## 4.5±1.5 5.7±1.7 (0.989)##
IL-1α (contra) 2.9±0.3 2.8±0.3 (0.872)## 2.9±0.3 2.8±0.3 (0.930)##
IL-1β (ipsi) 12.5±1.3 10.4±1.2 (0.976 )## 7.4±1.0 6.3±0.9 (0.971)##
IL-1β (contra) 7.4±0.8 7.1±0.9 (0.956 )## 9.4±0.7 9.3±0.7 (0.981)##
IL-2 (ipsi) 7.6±0.4 7.6±0.3 (0.933)## 7.8±1.1 8.0±1.1 (0.982)##
IL-2 (contra) 7.2±0.7 7.3±0.6 (0.972)## 6.2±0.4 6.5±0.5 (0.934)##
IL-4 (ipsi) 3.5±0.2 3.8±0.2 (0.934)## 4.0±0.7 4.6±0.7 (0.996 )##
IL-4 (contra) 3.7±0.3 3.6±0.7 (0.961)## 3.5±0.4 3.5±0.5 (0.986 )##
IL-5 (ipsi) 1.3±0.1N=7 2.2±0.2 (0.782)## 1.1±0.2N=7 2.0±0.3N=8 (0.914)##
IL-5 (contra) 1.3±0.1 1.5±0.1 (0.961)## 1.1±0.1 1.1±0.1N=7 (0.432)
IL-6 (ipsi) 14.2±0.8 14.3±0.7 (0.955 )## 27.1±7.1 28.4±7.6 (0.996 )
IL-6 (contra) 14.2±1.1 13.5±1.0 (0.979)## 13.6±1.2 13.1±1.3 (0.948 )##
IL-10 (ipsi) 11.9±1.3 16.0±1.1 (0.840)## 6.5±1.4 13.8±2.3 (0.870)##
IL-10 (contra) 11.2±1.1 13.9±1.2 (0.931)## 8.5±1.0 11.1±1.0 (0.605 )#
IL-12 (ipsi) 16.6±0.8 18.4±0.8 (0.975 )## 15.1±1.5 17.4±1.7 (0.998 )##
IL-12 (contra) 17.1±1.4 18.6±1.5 (0.989)## 15.7±1.1 17.6±1.3 (0.982)##
IL-13 (ipsi) 5.2±0.3 5.1±0.3 (0.946 )## 4.5±0.7 5.1±0.8 (0.975 )##
IL-13 (contra) 6.2±0.6 5.4±0.7 (0.977 )## 5.1±0.4 4.6±0.4 (0.906 )##
IL-17 (ipsi) 22.5±1.4 24.0±1.5 (0.942)## 21.0±3.1 23.2±3.5 (0.993)##
IL-17 (contra) 20.8±2.3 20.1±1.9 (0.960)## 16.0±1.1 16.0±1.0 (0.939)##
IL-18 (ipsi) 53.7±4.1 49.0±3.8 (0.973)## 46.1±2.2 42.7±2.0 (0.992)##
IL-18 (contra) 43.6±2.6 42.6±2.8 (0.971)## 53.3±2.9 52.4±2.7 (0.979)##
The concentration of the analytes are reported in pg/μg (±SEM). A regression analysis was performed to compare the data. R2 is shown within the bracket (italicized).
The F statistics for the regression analysis was signiﬁcant as indicated by #p<0.05 and ##p<0.005. N=10 for sham and N=9 for FPI groups, except when indicated
as subscript.
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Table 3 | Comparison of the level of analytes in the cortex detected by Bio-Plex vs. MAGPIX 24h after FPI.
Analytes Sham R2 FPI R2
Bio-Plex MAGPIX Bio-Plex MAGPIX
IP-10 (ipsi) 2.1±0.2 2.4±0.1 (0.840)## 1.6±0.3 2.3±0.5 (0.883)##
IP-10 (contra) 3.0±0.3 3.1±0.3 (0.984)## 2.4±0.2 2.3±0.2 (0.938 )##
CCL2 (ipsi) 16.8±3.2 16.6±3.2 (0.992)## 75.5±22.1 80.0±23.1 (0.997 )##
CCL2 (contra) 6.1±0.4 7.2±0.5 (0.954)## 13.9±3.3 14.0±2.7 (0.986 )##
CCL3 (ipsi) 10.2±1.5 9.9±1.5 (0.995 )## 20.8±6.0 20.9±6.0 (1.000)##
CCL3 (contra) 0.3±0.1 0.3±0.1N=6 (0.979)## 3.0±1.3 3.0±1.3 (0.999)##
CCL5 (ipsi) 12.0±0.8 11.7±0.7 (0.989)## 10.9±1.3 10.8±1.3 (0.993)##
CCL5 (contra) 9.7±0.7 10.2±0.7 (0.993)## 11.9±1.5 12.4±1.5 (0.998 )##
TNFα (ipsi) 0.8±0.2 1.1±0.2 (0.978 )## 2.6±0.8 3.1±0.8 (0.996 )##
TNFα (contra) 1.3±0.4 1.5±0.5 (0.996 )## 1.9±0.4 2.0±0.4 (0.985 )##
Eotaxin (ipsi) 3.2±0.2 2.9±0.2 (0.897 )## 2.8±0.4 2.7±0.4 (0.972)##
Eotaxin (contra) 5.6±0.5 5.4±0.5 (0.982)## 4.7±0.3 4.5±0.3 (0.786 )##
GRO KC (ipsi) 35.7±7.5 36.4±7.6 (0.998 )## 45.0±6.9 47.4±7.5 (0.992)##
GRO KC (contra) 11.9±1.8 11.8±1.8 (0.991)## 29.8±9.7 29.9±1.0 (0.999)##
Leptin (ipsi) 15.2±1.2 13.4±1.1 (0.904)## 12.3±1.2 10.9±0.1 (0.965 )##
Leptin (contra) 9.4±0.7 9.1±0.6 (0.832)## 9.6±0.9 9.2±1.3 (0.904)##
IFN γ (ipsi) 1.5±0.1 1.5±0.1 (0.728 )## 0.8±0.3N=8 1.0±0.2 (0.650)#
IFN γ (contra) 1.7±0.2 1.5±0.1 (0.655 )# 1.1±0.1 1.0±0.1 (0.478 )#
GMCSF (ipsi) 0.8±0.1 1.4±0.2N=9 (0.867 )## 0.8±0.2N=4 1.4±0.4N=4 (0.925 )#
GMCSF (contra) 1.5±0.2 1.5±0.2 (0.986 )## 1.0±0.1 1.0±0.1N=8 (0.828)#
The concentration of the analytes are reported in pg/μg (±SEM). A regression analysis was performed to compare the data. R2 is shown within the bracket (italicized).
The F statistics for the regression analysis was signiﬁcant as indicated by #p<0.05 and ##p<0.005. N=10 for sham and N=9 for FPI groups, except when indicated
as subscript.The lower N ′s for these cases are the result of undetectable values.
obtained using more established laser and ﬂow cytometry tech-
nology (Bio-Plex). In addition, when examining the patterns of
changes in the ipsi and contralateral side, both machines similarly
reported signiﬁcant differences when comparing sham animals to
FPI animals.
The Bio-Plex Manager software extrapolates data out of the
standard curve to provide a value, whereas the MAGPIX uses a
more stringent algorithmanddoes not report values at the extreme
low-end of the detection spectrum. In the context of low detection
concentrations, the Bio-Plex employs a more lenient algorithm
system which could lend itself to type I errors. Alternatively, the
MAGPIX instrument employs a more stringent algorithm and
is more prone to type II errors. The fact that signiﬁcant differ-
ences were detected by the Bio-Plex system for two of the analytes,
CCL3 and IL-10, but not by the MAGPIX system supports the
idea of type I vs. type II errors, respectively. The results from sub-
sequent comparisons using ELISA were consistent with the data
generated by the Bio-Plex system (Table 4). Despite these two
exceptions, both machines provide detection technology that is
sensitive enough to reliably detect analytes in the range of pg/μg
of protein in brain samples. Therefore, both machines are highly
adept at detecting small, albeit signiﬁcant alterations to the inﬂam-
matory milieu. Such technology can lead to very precise treatment
paradigms against speciﬁc inﬂammatory targets following brain
injury.
It should be noted that in addition to the differences in detec-
tion technology, both machines offer other distinctions that might
Table 4 | Effects of FPI on the cortical levels of IL-10 and CCL3 as
detected by Bio-Plex, MAGPIX, and traditional ELISA 24h after FPI.
Analytes Bio-Plex MAGPIX ELISA
CCL3 (ipsi) Sham 10.2±1.5 9.9±1.5 3.8±0.4
CCL3 (ipsi) FPI 20.8±6.0 20.9±6.0 15.6±9.2
CCL3 (contra) Sham 0.3±0.1 0.3±0.1N=6 3.0±0.3
CCL3 (contra) FPI 3.0±1.3* 3.0±1.3 3.9±0.3*
IL-10 (ipsi) Sham 11.9±1.3 16.0±1.1 80.9±7.8
IL-10 (ipsi) FPI 6.5±1.4* 13.8±2.3 57.5±4.8*
IL-10 (contra) Sham 11.2±1.1 13.9±1.2 51.8±5.4
IL-10 (contra) FPI 8.5±1.0 11.1±1.0 51.1±3.9
The concentration of the analyte is reported in pg/μg of total protein (±SEM). A
t-test was used to compare the data derived from each method *p<0.05 and
**p<0.005. N=10 for sham and N=9 for FPI groups, except CCL3 sham group
in contralateral cortex in the MAGPIX data, where N=6 (indicated as subscript).
be of interest to the end-user. For example, the MAGPIX sys-
tem is cheaper to purchase and to maintain, but is limited to
simultaneous analysis of a maximum of 50 analytes. Alternatively,
the Bio-Plex system is capable of simultaneous analysis of up to
100 analytes. A recent comparison (Fu et al., 2010) between ﬁve
different multiplex assay systems, but not including the MAG-
PIX system, concluded that Bio-Plex system was the most ideal
for quantiﬁcation. The current study shows that the MAGPIX
provides data of equal reliability.
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There are large gaps in our knowledge of the precise inﬂam-
matory response following brain injury. Certainly, these gaps
will narrow as newer technology makes proteomic analysis
more efﬁcient and cost–effective. The present study demon-
strates alteration of several cytokines 24 h after FPI. For exam-
ple, a signiﬁcant elevation of CCL2 was observed in both ipsi-
lateral and contralateral cortex after FPI. CCL2 plays a cru-
cial role in promotion of macrophage inﬁltration in damaged
brain parenchyma and is observed to be increased in the cere-
brospinal ﬂuid (CSF) of human TBI patients for 10 days after
injury (Semple et al., 2010). CCL2 and its receptor, CCR2,
have been observed to be expressed in astrocytes and reactive
microglia after experimental brain injury and seizures (Glabin-
ski et al., 1996; Gourmala et al., 1997; Foresti et al., 2009).
Considering that CCL2 is often used as a general marker
for inﬂammation (Conductier et al., 2010), it is quite clear
that brain injury results in a rapid and robust inﬂammatory
response. Indeed, CCL2 also may be involved in mediating
some of the secondary effects of brain injuries (Semple et al.,
2010).
CONCLUSION
The results show that two distinct methods of multiplex assay con-
sistently report cytokine levelswith a highdegree of sensitivity. The
use of these technologies allows for large-scale proteomic analysis
of the inﬂammatory response in the brain. Such technology can
pave the way for future therapeutic interventions. In the context
of brain injury, many cytokines were altered 24 h after FPI, but
future studies are needed in multiple brain regions and at multi-
ple time points after injury to elucidate its exact mechanisms and
consequences.
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